Michael D. Berquist

Researcher

UAMS

Last publication 2025 Last refreshed 2026-05-16

faculty

11 h-index 41 pubs 364 cited

Research Areas

Links

ORCID Lab Website UAMS TRI Profile

OverviewAI-generated summary

Michael D. Berquist's research program investigates the neurobiological and pharmacological underpinnings of substance use disorders and related conditions. His work frequently utilizes animal models, particularly rats and mice, to examine the effects of various drugs, including stimulants like methamphetamine, and central nervous system depressants such as ethanol and opioids.

Berquist's publications explore topics ranging from the impact of environmental factors like limited bedding on ethanol consumption to the neuroinflammatory consequences of chronic ethanol administration. He also studies the interaction of different drug compounds, such as buprenorphine and norbuprenorphine, and investigates the potential therapeutic applications of monoclonal antibodies for treating methamphetamine use. His collaborations include work with Lisa K. Brents, Brian J. Parks, and Julia Tobacyk at the University of Arkansas for Medical Sciences, with whom he has co-authored multiple publications.

Metrics

h-index: 11
Publications: 41
Citations: 364

Selected Publications

Comparison between a chimeric anti-methamphetamine monoclonal antibody and humanized antibodies on pharmacological effects of methamphetamine (2025)

DOI OpenAlex
Identifying a Lead Candidate Anti-methamphetamine Monoclonal Antibody for IND-enabling Studies: Cross-reactivity and Locomotor Activity (2024)

DOI OpenAlex
Limited bedding and nesting increases ethanol drinking in female rats (2024)

9 citations DOI OpenAlex
Interaction between buprenorphine and norbuprenorphine in neonatal opioid withdrawal syndrome (2023)

2 citations DOI OpenAlex
Effects of a two-hit model of early life adversity on oral ethanol self-administration and adrenergic receptor expression in adolescent rats (2023)

DOI OpenAlex
481 Interactions between buprenorphine and norbuprenorphine in neonatal opioid withdrawal syndrome (2023)

DOI OpenAlex
Interaction between buprenorphine and norbuprenorphine in neonatal opioid withdrawal syndrome. (2022)

DOI OpenAlex
Effects of chronic and binge ethanol administration on mouse cerebellar and hippocampal neuroinflammation (2022)

16 citations DOI OpenAlex
Methamphetamine‐Induced Proteomic Changes Within the Neuroinflammatory TLR4 Pathway Persist After Long‐Term Self‐Administration in Rats (2022)

DOI OpenAlex
Effects of prenatal opioid exposure and early life adversity on opioid‐induced antinociception (2022)

DOI OpenAlex
Effects of 5-HT2A receptor agonist 2,5-dimethoxy-4-iodoamphetamine on alcohol consumption in Long–Evans rats (2021)

22 citations DOI OpenAlex